Familial hemophagocytic lymphohistiocytosis type 4 (FHL4) with a rare STX11 genetic variation and leukoencephalopathy: a case report

Background: Familial HLH (FHL), if untreated, has often a fatal outcome.1 Neurological symptoms are seen in about two-thirds of FHL patients as a result of leptomeningeal and parenchymal infiltration by lymphocytes and macrophages, and suggest a poor prognosis.2 Case report: We present the case of a...

Full description

Saved in:
Bibliographic Details
Main Authors: Vaishnavi Sreenivasan, Kawaldeep Kaur, Sanghamitra Ray, Amitabh Singh, Sumit Mehndiratta, Nidhi Chopra
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Pediatric Hematology Oncology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468124525000191
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Familial HLH (FHL), if untreated, has often a fatal outcome.1 Neurological symptoms are seen in about two-thirds of FHL patients as a result of leptomeningeal and parenchymal infiltration by lymphocytes and macrophages, and suggest a poor prognosis.2 Case report: We present the case of a four-year-old girl with familial hemophagocytic lymphohistiocytosis type 4 (FHL4) with a rare homozygous mutation of STX11 who was found to have leukoencephalopathy on neuroimaging. She had an unusual finding of low ferritin on initial evaluation that was misleading for the final diagnosis. Conclusion: CNS involvement portends a poor prognosis in HLH and must be kept in mind early in the diagnosis of FHL. Even in the presence of subtle symptoms, active investigation must be done in such cases as timely treatment is rewarded with good results.
ISSN:2468-1245